# Myla Lai-Goldman

> Myla Lai-Goldman is a seed investor at Hatteras Venture Partners backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Hatteras Venture Partners](https://shizune.co/investors/profile/hatteras-venture-partners)
- Location: South Burlington, United States
- Total investments: 1
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/myla-lai-goldman-362b4314

Myla Lai-Goldman is a Co-Founder and Chair at GeneCentric Therapeutics and a Venture Partner at Hatteras Venture Partners. Myla was an Executive VP, CMO, and CSO at Labcorp. She attended Columbia University Vagelos College of Physicians and Surgeons and the University of Pennsylvania,

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Medical Device | 1 | 100% |
| Machine Learning | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biocogniv | More than a decade since the HITECH Act established a timeline for EHR adoption, US hospitals today find themselves generating more clinical and administrative data on any given day than previously thought possible. Yet clinical operations are still based on subjective decision-making and traditional processes that ignore not only the raw data, butalso the valuable efficiency improvements that can be automatically derived from them.Biocogniv picks up where the EHR transformation left off and introduces real-time intelligence on top of this vast backdrop of data, to improve the quality, cost, and ultimately access to care in US health systems. | $6M | Seed | Mar 16, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Breyer Capital](https://shizune.co/investors/profile/breyer-capital) — VC Fund, 2 deals together
- [1984 Ventures](https://shizune.co/investors/profile/1984-ventures) — VC Fund, 1 deal together
- [AltaIR Capital](https://shizune.co/investors/profile/altair) — VC Fund, 1 deal together
- [Hula](https://shizune.co/investors/profile/hula-b442) — VC Fund, 1 deal together
- [Inflect Health](https://shizune.co/investors/profile/inflect-health) — VC Fund, 1 deal together
- [Promus Ventures](https://shizune.co/investors/profile/promus-ventures) — VC Fund, 1 deal together

## About Hatteras Venture Partners

VC Fund · Durham, United States

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

5 contacts available at Hatteras Venture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Douglas Reed | General Partner | https://shizune.co/investors/profile/douglas-reed |
| Jeff Terrell | General Partner | https://shizune.co/investors/profile/jeff-terrell |
| Myla Lai-Goldman | Venture Partner | https://shizune.co/investors/profile/myla-lai-goldman |
| Christy L. Shaffer | General Partner | https://shizune.co/investors/profile/christy-l-shaffer |
| Clay B. Thorp | General Partner and Co-Founder | https://shizune.co/investors/profile/clay-b-thorp |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Myla Lai-Goldman invest in?

Myla Lai-Goldman invests primarily in Health Care, Medical Device and Machine Learning startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Myla Lai-Goldman last invest?

The most recent investment recorded for Myla Lai-Goldman closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co